Pyronaridine Artesunate (3:1) Versus Coartem® in P Falciparum Malaria Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00422084
Recruitment Status : Completed
First Posted : January 15, 2007
Last Update Posted : May 20, 2008
Shin Poong Pharmaceuticals
Information provided by:
Medicines for Malaria Venture